Bone matrix regulates osteoclast differentiation and annexin A8 gene expression

Journal of Cellular Physiology

Volumn 226, Issue 12, 2011, Pages 3413-3421

  Crotti, Tania N ^a   O'Sullivan, Regina P ^b   Shen, Zhenxin ^b   Flannery, Merrilee R ^b   Fajardo, Roberto J ^c   Ross, F Patrick ^d   Goldring, Steven R ^d   Mchugh, Kevin P ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; ANNEXIN A8; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CULTURE; BONE MATRIX; BONE MINERAL; BONE MINERALIZATION; CALVARIA; CONTROLLED STUDY; CYTOSKELETON; GENE EXPRESSION; GENE INTERACTION; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; RNA INTERFERENCE; UPREGULATION;

ACTINS; ANIMALS; ANNEXINS; BONE MATRIX; CELL DIFFERENTIATION; CELL SHAPE; CELLS, CULTURED; CYTOSKELETON; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOCLASTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC; UP-REGULATION;

MURINAE;

EID: 80053137241     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22699     Document Type: Article

References (59)

1. Athanasou NA. 1996. Current concepts review: Cellular biology of bone-resorbing cells. J Bone Joint Surg 78-A: 1096-1113.
2. Chambers TJ. 2000. Regulation of the differentiation and function of osteoclasts. J Pathol 192: 4-13.
3. Coxon FP, Taylor A. 2008. Vesicular trafficking in osteoclasts. Semin Cell Dev Biol 19: 424-433.
4. Cuetara BL, Crotti TN, O'Donoghue AJ, McHugh KP. 2006. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line. In Vitro Cell Dev Biol Anim 42: 182-188.
5. de Graauw M, Tijdens I, Smeets MB, Hensbergen PJ, Deelder AM, van de Water B. 2008. Annexin A2 phosphorylation mediates cell scattering and branching morphogenesis via cofilin activation. Mol Cell Biol 28: 1029-1040.
6. Erikson E, Erikson RL. 1980. Identification of a cellular protein substrate phosphorylated by the avian sarcoma virus-transforming gene product. Cell 21: 829-836.
7. Everts V, Korper W, Hoeben KA, Jansen ID, Bromme D, Cleutjens KB, Heeneman S, Peters C, Reinheckel T, Saftig P, Beertsen W. 2006. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: Differences between calvaria and long bone. J Bone Miner Res 21: 1399-1408.
8. Faccio R, Fujikawa K, Teitelbaum SL, Ross FP, Swat W. 2002. Vav3 regulates osteoclast function by controlling reorganization of the cytoskeleton and integrin signaling. Mol Biol Cell 13: 2679.
9. Faccio R, Teitelbaum SL, Fujikawa K, Chappel J, Zallone A, Tybulewicz VL, Ross FP, Swat W. 2005. Vav3 regulates osteoclast function and bone mass. Nat Med 11: 284-290.
10. Faccio R, Takeshita S, Colaianni G, Chappel J, Zallone A, Teitelbaum SL, Ross FP. 2007. M-CSF regulates the cytoskeleton via recruitment of a multimeric signaling complex to c-Fms Tyr-559/697/721. J Biol Chem 282: 18991-18999.
11. Futter CE, White IJ. 2007. Annexins and endocytosis. Traffic 8: 951-958.
12. Gerke V, Moss SE. 2002. Annexins: From structure to function. Physiol Rev 82: 331-371.
13. Gerke V, Creutz CE, Moss SE. 2005. Annexins: Linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 6: 449-461.
14. 2+ and phospholipid. FEBS Lett 192: 79-82.
15. Glowacki J, Jasty M, Goldring S. 1986. Comparison of multinucleated cells elicited in rats by particulate bone, polyethylene, or polymethylmethacrylate. J Bone Miner Res 1: 327-331.
16. Goebeler V, Ruhe D, Gerke V, Rescher U. 2006. Annexin A8 displays unique phospholipid and F-actin binding properties. FEBS Lett 580: 2430-2434.
17. Goebeler V, Poeter M, Zeuschner D, Gerke V, Rescher U. 2008. Annexin A8 regulates late endosome organization and function. Mol Biol Cell 19: 5267-5278.
18. Goldring SR, Roelke M, Glowacki J. 1988. Multinucleated cells elicited in response to implants of devitalized bone particles possess receptors for calcitonin. J Bone Miner Res 3: 117-120.
19. Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR. 1998. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 152: 943-951.
20. Hattersley G, Chambers TJ. 1989. Calcitonin receptors as markers for osteoclastic differentiation: Correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures. Endocrinology 125: 1606-1612.
21. Hayes MJ, Rescher U, Gerke V, Moss SE. 2004. Annexin-actin interactions. Traffic 5: 571-576.
22. Hayes MJ, Shao DM, Grieve A, Levine T, Bailly M, Moss SE. 2009. Annexin A2 at the interface between F-actin and membranes enriched in phosphatidylinositol 4, 5, -bisphosphate. Biochim Biophys Acta 1793: 1086-1095.
23. Holliday LS, Bubb MR, Jiang J, Hurst IR, Zuo J. 2005. Interactions between vacuolar H+-ATPases and microfilaments in osteoclasts. J Bioenerg Biomembr 37: 419-423.
24. Ishida N, Hayashi K, Hoshijima M, Ogawa T, Koga S, Miyatake Y, Kumegawa M, Kimura T, Takeya T. 2002. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem 277: 41147-41156.
25. Karsdal MA, Fjording MS, Foged NT, Delaisse JM, Lochter A. 2001. Transforming growth factor-beta-induced osteoblast elongation regulates osteoclastic bone resorption through a p38 mitogen-activated protein kinase- and matrix metalloproteinase-dependent pathway. J Biol Chem 276: 39350-39358.
26. Kornak U, Kasper D, Bosl MR, Kaiser E, Schweizer M, Schulz A, Friedrich W, Delling G, Jentsch TJ. 2001. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104: 205-215.
27. Laumonnier Y, Syrovets T, Burysek L, Simmet T. 2006. Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes. Blood 107: 3342-3349.
28. Lee ZH, Kim HH. 2003. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun 305: 211-214.
29. Li C, Wong WH. 2001. Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection. Proc Natl Acad Sci USA 98: 31-36.
30. Li F, Chung H, Reddy SV, Lu G, Kurihara N, Zhao AZ, Roodman GD. 2005. Annexin II stimulates RANKL expression through MAPK. J Bone Miner Res 20: 1161-1167.
31. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
32. Lu G, Maeda H, Reddy SV, Kurihara N, Leach R, Anderson JL, Roodman GD. 2006. Cloning and characterization of the annexin II receptor on human marrow stromal cells. J Biol Chem 281: 30542-30550.
33. Lutgens SP, Cleutjens KB, Daemen MJ, Heeneman S. 2007. Cathepsin cysteine proteases in cardiovascular disease. Faseb J 21: 3029-3041.
34. McHugh KP, Kitazawa S, Teitelbaum SL, Ross FP. 2001. Cloning and characterization of the murine beta(3) integrin gene promoter: Identification of an interleukin-4 responsive element and regulation by STAT-6. J Cell Biochem 81: 320-332.
35. Menaa C, Devlin RD, Reddy SV, Gazitt Y, Choi SJ, Roodman GD. 1999. Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures. J Clin Invest 103: 1605-1613.
36. Michou L, Chamoux E, Couture J, Morissette J, Brown JP, Roux S. 2009. Gene expression profile in osteoclasts from patients with Paget's disease of bone. Bone 46: 598-603.
37. Morel E, Parton RG, Gruenberg J. 2009. Annexin A2-dependent polymerization of actin mediates endosome biogenesis. Dev Cell 16: 445-457.
38. Moss SE, Morgan RO. 2004. The annexins. Genome Biol 5: 219.
39. Novack DV, Teitelbaum SL. 2008. The osteoclast: Friend or foe? Annu Rev Pathol 3: 457-484.
40. Quintanilla-Dieck MJ, Codriansky K, Keady M, Bhawan J, Runger TM. 2009. Expression and regulation of cathepsin K in skin fibroblasts. Exp Dermatol 18: 596-602.
41. Rescher U, Gerke V. 2004. Annexins-unique membrane binding proteins with diverse functions. J Cell Sci 117: 2631-2639.
42. Rescher U, Ludwig C, Konietzko V, Kharitonenkov A, Gerke V. 2008. Tyrosine phosphorylation of annexin A2 regulates Rho-mediated actin rearrangement and cell adhesion. J Cell Sci 121: 2177-2185.
43. Roodman GD. 1999. Cell biology of the osteoclast. Exp Hem 27: 1229-1241.
44. Ross FP, Teitelbaum SL. 2005. alphavbeta3 and macrophage colony-stimulating factor: Partners in osteoclast biology. Immunol Rev 208: 88-105.
45. Rucci N, Rufo A, Alamanou M, Capulli M, Del Fattore A, Ahrman E, Capece D, Iansante V, Zazzeroni F, Alesse E, Heinegard D, Teti A. 2009. The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis. J Cell Biol 187: 669-683.
46. Saltel F, Destaing O, Bard F, Eichert D, Jurdic P. 2004. Apatite-mediated actin dynamics in resorbing osteoclasts. Mol Biol Cell 15: 5231-5241.
47. Saltel F, Chabadel A, Bonnelye E, Jurdic P. 2008. Actin cytoskeletal organisation in osteoclasts: A model to decipher transmigration and matrix degradation. Eur J Cell Biol 87: 459-468.
48. Shen Z, Crotti TN, McHugh KP, Matsuzaki K, Gravallese EM, Bierbaum BE, Goldring SR. 2006. The role played by cell-substrate interactions in the pathogenesis of osteoclast-mediated peri-implant osteolysis. Arthritis Res Ther 8: R70.
49. Takahashi S, Reddy SV, Chirgwin JM, Devlin R, Haipek C, Anderson J, Roodman GD. 1994. Cloning and identification of annexin II as an autocrine/paracrine factor that increases osteoclast formation and bone resorption. J Biol Chem 269: 28696-28701.
50. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3: 889-901.
51. Tanaka S, Suzuki H, Yamauchi H, Nakamura I, Nakamura K. 2006. Signal transduction pathways of calcitonin/calcitonin receptor regulating cytoskeletal organization and bone-resorbing activity of osteoclasts. Cell Mol Biol (Noisy-le-grand) 52: 19-23.
52. Taranta A, Migliaccio S, Recchia I, Caniglia M, Luciani M, De Rossi G, Dionisi-Vici C, Pinto RM, Francalanci P, Boldrini R, Lanino E, Dini G, Morreale G, Ralston SH, Villa A, Vezzoni P, Del Principe D, Cassiani F, Palumbo G, Teti A. 2003. Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis. Am J Pathol 162: 57-68.
53. Teitelbaum S. 2000. Bone resorption by osteoclasts. Science 289: 1504-1508.
54. Tezuka K, Nemoto K, Tezuka Y, Sato T, Ikeda Y, Kobori M, Kawashima H, Eguchi H, Hakeda Y, Kumegawa M. 1994. Identification of matrix metalloproteinase 9 in rabbit osteoclasts. J Biol Chem 269: 15006-15009.
55. +-ATPase type in the ruffled border of ostoclasts. J Cell Biol 111: 1305-1311.
56. Yang G, Zaidi M, Zhang W, Zhu LL, Li J, Iqbal J, Varbanov A, Gross G, Phipps R, Troen BR, Sun L. 2008. Functional grouping of osteoclast genes revealed through microarray analysis. Biochem Biophys Res Commun 366: 352-359.
57. Youn MY, Fujiyama-Nakamura S, Takada I, Imai Y, Kato S. 2010. Identification of osteoclastic factors in the nuclear envelope of mature, multinucleated osteoclasts. Biosci Biotechnol Biochem 74: 1956-1959 .
58. Zhao HB, Ito YJ, Chappel J, Andrews NW, Teitelbaum SL, Ross FP. 2008. Synaptotagmin VII regulates bone remodeling by modulating osteoclast and osteoblast secretion. Dev Cell 14: 914-925.
59. Zou W, Teitelbaum SL. 2010. Integrins, growth factors, and the osteoclast cytoskeleton. Ann NY Acad Sci 1192: 27-31.